Circulating immune complexes and immunoglobulin M-class rheumatoid factor in rats bearing mammary adenocarcinomas which vary in ability to metastasize.

Abstract:

:In order to explore whether immune complex (IC) formation and immunoglobulin M-class rheumatoid factor (RF) synthesis are related to tumor progression, solid-phase enzyme immunoassays were used to test for ICs and RF in rats bearing three different syngeneic mammary adenocarcinomas. The mammary adenocarcinoma cell lines used produced either extensive metastasis (13762), metastasis in only a proportion of the animals given injections (R3230AC), or no metastasis (DMBA8). DMBA8 and 13762 tumor-bearing rats developed only low levels of circulating ICs. Of 18 animals bearing R3230AC tumors, four developed palpable lymph node metastasis (macrometastasis), while another five showed evidence of metastasis only upon histological examination (micrometastasis). R3230AC tumor-bearing animals which did not develop metastasis were found to have significantly higher IC levels than those rats with metastasis. Several sera from rats bearing R3230AC tumors were fractionated by molecular sieve chromatography. Most of the ICs in these sera were 7S to 19S in size. Significant RF synthesis occurred only in rats bearing R3230AC tumors and only during terminal tumor growth. These results show that IC formation and RF synthesis varies in animals bearing different mammary adenocarcinomas.

journal_name

Cancer Res

journal_title

Cancer research

authors

Hoon DB,Ziola B,Carlsen S,Warrington R,Ramshaw I

subject

Has Abstract

pub_date

1983-01-01 00:00:00

pages

114-9

issue

1

eissn

0008-5472

issn

1538-7445

journal_volume

43

pub_type

杂志文章
  • Responses of amphibian embryos and blastomeres to a tumor-promoting phorbol ester.

    abstract::Phorbol ester tumor promoters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) alter the morphology and differentiated states of numerous cell types in vitro. It is likely that these molecules are teratogenic for vertebrate embryos in which cytodifferentiation, cell-tissue interactions, and cellular motility are pro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ellinger MS

    更新日期:1982-07-01 00:00:00

  • Serine-Glycine-One-Carbon Metabolism: The Hidden Achilles Heel of MYCN-Amplified Neuroblastoma?

    abstract::In this issue of Cancer Research, Xia and colleagues show that MYC-induced metabolic reprograming results in dependency on the serine-glycine-one-carbon (SGOC) metabolic pathway in neuroblastoma. This occurs through MYCN and ATF4 activation of the SGOC biosynthetic pathway in MYCN-amplified cells. Furthermore, inhibit...

    journal_title:Cancer research

    pub_type: 评论,杂志文章

    doi:10.1158/0008-5472.CAN-19-1816

    authors: Garcia AR,Arsenian-Henriksson M

    更新日期:2019-08-01 00:00:00

  • Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas.

    abstract::Gastrointestinal adenocarcinomas (GIAC) of the tubular gastrointestinal (GI) tract including esophagus, stomach, colon, and rectum comprise most GI cancers and share a spectrum of genomic features. However, the unified epigenomic changes specific to GIAC are poorly characterized. Using 907 GIAC samples from The Cancer...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-0390

    authors: Pan J,Silva TC,Gull N,Yang Q,Plummer JT,Chen S,Daigo K,Hamakubo T,Gery S,Ding LW,Jiang YY,Hu S,Xu LY,Li EM,Ding Y,Klempner SJ,Gayther SA,Berman BP,Koeffler HP,Lin DC

    更新日期:2020-07-01 00:00:00

  • Mouse models of subcutaneous spleen reservoir for multiple portal venous injections to treat liver malignancies.

    abstract::Dog and rat animal models have been developed for repeated intravascular administrations to the liver. However, mice have generally been considered too small to use for these models. This study describes the development of mouse models that permit the establishment of liver metastases that can be subsequently treated ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2631

    authors: Kasuya H,Kuruppu DK,Donahue JM,Choi EW,Kawasaki H,Tanabe KK

    更新日期:2005-05-01 00:00:00

  • Rhabdomyosarcoma lysis by T cells expressing a human autoantibody-based chimeric receptor targeting the fetal acetylcholine receptor.

    abstract::Rhabdomyosarcomas are the most frequent malignant soft tissue tumors of childhood; however, because current multimodality treatments fail to improve the poor survival rate of children with metastatic rhabdomyosarcoma, new treatments are required. We previously identified the gamma-subunit of the fetal acetylcholine re...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0542

    authors: Gattenlöhner S,Marx A,Markfort B,Pscherer S,Landmeier S,Juergens H,Müller-Hermelink HK,Matthews I,Beeson D,Vincent A,Rossig C

    更新日期:2006-01-01 00:00:00

  • Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).

    abstract::Eleutherobin is a novel natural product isolated from a marine soft coral that is extremely potent for inducing tubulin polymerization in vitro and is cytotoxic for cancer cells with an IC50 similar to that of paclitaxel. This compound is cross-resistant along with other multidrug-resistant agents against P-glycoprote...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Long BH,Carboni JM,Wasserman AJ,Cornell LA,Casazza AM,Jensen PR,Lindel T,Fenical W,Fairchild CR

    更新日期:1998-03-15 00:00:00

  • Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.

    abstract::Hepsulfam (NSC 329680, 1,7-heptanediol disulfamate) is an alkylating agent that showed excellent activity against mouse and human mammary carcinoma in preclinical studies. We therefore studied the cytotoxicity of this drug in six human breast cancer cell lines (AdrRMCF7, WTMCF7, Hs578T, MDA-MB-231, T47D, and MDA-MB-46...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Armstrong DK,Gordon GB,Hilton J,Streeper RT,Colvin OM,Davidson NE

    更新日期:1992-03-15 00:00:00

  • Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen.

    abstract::A link between colitis and colon cancer is well established, but the mechanisms regulating inflammation in this context are not fully defined. Given substantial evidence that hemostatic system components are powerful modulators of both inflammation and tumor progression, we used gene-targeted mice to directly test the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3465

    authors: Steinbrecher KA,Horowitz NA,Blevins EA,Barney KA,Shaw MA,Harmel-Laws E,Finkelman FD,Flick MJ,Pinkerton MD,Talmage KE,Kombrinck KW,Witte DP,Palumbo JS

    更新日期:2010-04-01 00:00:00

  • BCL2 suppresses PARP1 function and nonapoptotic cell death.

    abstract::BCL2 suppresses apoptosis by binding the BH3 domain of proapoptotic factors and thereby regulating outer mitochondrial membrane permeabilization. Many tumor types, including B-cell lymphomas and chronic lymphocytic leukemia, are dependent on BCL2 for survival but become resistant to apoptosis after treatment. Here, we...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-4204

    authors: Dutta C,Day T,Kopp N,van Bodegom D,Davids MS,Ryan J,Bird L,Kommajosyula N,Weigert O,Yoda A,Fung H,Brown JR,Shapiro GI,Letai A,Weinstock DM

    更新日期:2012-08-15 00:00:00

  • Phase I/pharmacokinetic study of topotecan by 24-hour continuous infusion weekly.

    abstract::Topotecan (SK&F 104864, hycamptamine, NSC 609699) is believed to exert its cytotoxic effects through inhibition of topoisomerase I, the activity of which recovers rapidly on removal of the drug in vitro. In vivo studies show that the activity of topotecan is schedule dependent, favoring repeated doses. Early human stu...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Haas NB,LaCreta FP,Walczak J,Hudes GR,Brennan JM,Ozols RF,O'Dwyer PJ

    更新日期:1994-03-01 00:00:00

  • Decreased activation of carcinogens in the liver of carcinogen-resistant rats.

    abstract::We have developed a new strain of rats (resistant rat) which exhibit resistance against the carcinogenic action of several carcinogenic compounds. In the present study, we compared the ability of resistant rat liver to activate 3'-methyl-4-dimethylaminoazobenzene and 2-acetylaminofluorene to highly reactive metabolite...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yano M,Higashi T,Kano S,Tateishi N,Kido Y,Mori T,Higashi K,Sakamoto Y

    更新日期:1989-10-01 00:00:00

  • Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.

    abstract::PD115934 (NSC 366140) is a soluble pyrazoloacridine derivative presently undergoing preclinical toxicology evaluation with the anticipation of Phase I human investigation. The agent displayed both human and murine solid tumor selectivity in vitro in a soft agar disk diffusion assay, relative to its activity against mu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: LoRusso P,Wozniak AJ,Polin L,Capps D,Leopold WR,Werbel LM,Biernat L,Dan ME,Corbett TH

    更新日期:1990-08-15 00:00:00

  • Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice.

    abstract::Human CYP2A6 has been recognized as being involved in the mutagenic activation of promutagens such as the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Methoxsalen (8-methoxypsoralen) was reported to inhibit CYP2A6. In the present study, the inhibitory effects of methoxsalen on NN...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Takeuchi H,Saoo K,Yokohira M,Ikeda M,Maeta H,Miyazaki M,Yamazaki H,Kamataki T,Imaida K

    更新日期:2003-11-15 00:00:00

  • Chemical enhancers of cytokine signaling that suppress microfilament turnover and tumor cell growth.

    abstract::The transforming growth factor-beta (TGF-beta) family of cytokines regulates cell proliferation, morphogenesis, and specialized cell functions in metazoans. Herein, we screened a compound library for modifiers of TGF-beta signaling in NMuMG epithelial cells using a cell-based assay to measure Smad2/3 nuclear transloca...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2542

    authors: Park HJ,Partridge E,Cheung P,Pawling J,Donovan R,Wrana JL,Dennis JW

    更新日期:2006-04-01 00:00:00

  • Formalizing an integrative, multidisciplinary cancer therapy discovery workflow.

    abstract::Although many clinicians and researchers work to understand cancer, there has been limited success to effectively combine forces and collaborate over time, distance, data, and budget constraints. Here we present a workflow template for multidisciplinary cancer therapy that was developed during the 2nd Annual Workshop ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0310

    authors: McGuire MF,Enderling H,Wallace DI,Batra J,Jordan M,Kumar S,Panetta JC,Pasquier E

    更新日期:2013-10-15 00:00:00

  • Potential topoisomerase II DNA-binding sites at the breakpoints of a t(9;11) chromosome translocation in acute myeloid leukemia.

    abstract::We have examined a t(9;11)(p22;q23) chromosome translocation in an acute myeloid leukemia of an infant. The breakpoints on the two chromosomes occurred within introns of the involved genes: AF-9 on chromosome 9, and ALL-1 on chromosome 11. Sequence analysis identified heptamers flanking the breakpoints on both chromos...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Negrini M,Felix CA,Martin C,Lange BJ,Nakamura T,Canaani E,Croce CM

    更新日期:1993-10-01 00:00:00

  • Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.

    abstract::The estrogen receptor (ER)-positive human breast cancer cell line T 47D exhibited genetic instability under cell culture conditions which maintained almost continuous exponential growth. This resulted in the spontaneous generation of three ER-positive sublines with a range of DNA ploidies and distinctive phenotypes. O...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reddel RR,Alexander IE,Koga M,Shine J,Sutherland RL

    更新日期:1988-08-01 00:00:00

  • Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.

    abstract::Patients with disseminated Ewing's family of tumors (ESFT) often experience drug-resistant relapse. We hypothesize that targeting minimal residual disease with the cytotoxic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR; fenretinide) may decrease relapse. We determined the following: (a) 4-HPR cytotoxicity against 12...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-0377

    authors: Batra S,Reynolds CP,Maurer BJ

    更新日期:2004-08-01 00:00:00

  • Characterization of a nuclear antigen (Mr 150,000) associated with cell proliferation.

    abstract::In the course of development of a "library" of monoclonal antibodies to nucleolar proteins, a monoclonal antibody to a nuclear antigen with a molecular weight of 150,000 was obtained. Using this monoclonal antibody as an immunocytochemical probe, low immunofluorescence was demonstrated in human peripheral blood lympho...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chatterjee A,Durban E,Busch H

    更新日期:1988-12-15 00:00:00

  • Circulating Tumor DNA Provides a Sneak Peek into Treatment Responses in Non-Small Cell Lung Cancer.

    abstract::Circulating tumor DNA (ctDNA) holds great promise as a noninvasive diagnostic tool to guide treatment for patients with lung cancer. Two studies by Phallen and colleagues and Anagnostou and colleagues correlated sensitive measures of ctDNA with clinical responses to tyrosine kinase inhibitors (TKI) and immune checkpoi...

    journal_title:Cancer research

    pub_type: 评论,杂志文章

    doi:10.1158/0008-5472.CAN-19-0231

    authors: Zou T,Meyerson M

    更新日期:2019-03-15 00:00:00

  • Activating transcription factor 2 and c-Jun-mediated induction of FoxP3 for experimental therapy of mammary tumor in the mouse.

    abstract::FOXP3 is inactivated in breast cancer cells by a number of mechanisms, including somatic mutations, deletion, and epigenetic silencing. Because the mutation and deletion are usually heterozygous in the cancer samples, it is of interest to determine whether the gene can be induced for the purpose of cancer therapy. Her...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0778

    authors: Liu Y,Wang Y,Li W,Zheng P,Liu Y

    更新日期:2009-07-15 00:00:00

  • Effects of prostacyclin on tumor cell-induced platelet aggregation.

    abstract::Prostacyclin has been evaluated for its ability to inhibit tumor cell-induced platelet aggregation (TCIPA) induced by several rodent tumor lines: B16a (melanoma); 3LL (carcinoma); 15091A (adenocarcinoma); and W256 (carcinosarcoma). Aggregation of human platelets by all four lines was inhibited by prostaglandin I2 (PGI...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Menter DG,Onoda JM,Taylor JD,Honn KV

    更新日期:1984-02-01 00:00:00

  • Identification of a tumor-suppressive human-specific microRNA within the FHIT tumor-suppressor gene.

    abstract::Loss or attenuated expression of the tumor-suppressor gene FHIT is associated paradoxically with poor progression of human tumors. Fhit promotes apoptosis and regulates reactive oxygen species; however, the mechanism by which Fhit inhibits tumor growth in animals remains unclear. In this study, we used a multidiscipli...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3279

    authors: Hu B,Ying X,Wang J,Piriyapongsa J,Jordan IK,Sheng J,Yu F,Zhao P,Li Y,Wang H,Ng WL,Hu S,Wang X,Wang C,Zheng X,Li W,Curran WJ,Wang Y

    更新日期:2014-04-15 00:00:00

  • Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer.

    abstract::TP53 gene mutation is associated with poor prognosis in breast cancer, but additional biomarkers that can further refine the impact of the p53 pathway are needed to achieve clinical utility. In this study, we evaluated a role for the HDMX-S/FL ratio as one such biomarker, based on its association with other suppressor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-2637

    authors: Grawenda AM,Møller EK,Lam S,Repapi E,Teunisse AF,Alnæs GI,Børresen-Dale AL,Kristensen VN,Goding CR,Jochemsen AG,Edvardsen H,Bond GL

    更新日期:2015-02-15 00:00:00

  • Cellular and serum involvement in protection against Friend leukemia virus.

    abstract::Treatment of mice with the immunomodulator pyran copolymer inhibited leukemogenesis produced by Friend leukemia virus (FLV) complex, as evidenced by inhibition of the spleen focus-forming virus and lymphatic leukemia virus, as well as by a significant decrease in splenomegaly. In this report we present data suggesting...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Schuller GB,Morahan PS

    更新日期:1977-11-01 00:00:00

  • Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma.

    abstract::The development of colon carcinomas is associated with allelic deletions on chromosomes 5q, 17p, and 18q. The DCC gene located on chromosome 18q21.3 codes for a potential tumor suppressor gene related to cellular adhesion receptors. We investigated the expression of this gene in several pancreatic carcinoma cell lines...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Höhne MW,Halatsch ME,Kahl GF,Weinel RJ

    更新日期:1992-05-01 00:00:00

  • Regression of canine mammary carcinoma after immunoadsorption therapy.

    abstract::The plasma of dogs afflicted with mammary carcinoma was perfused through chambers bearing Staphylococcus aureus Cowan strain I in an attempt to remove tumor-promoting, immunosuppressive immune complexes from the peripheral blood of these animals. In this canine model of spontaneous mammary carcinoma, reduction of brea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Holohan TV,Phillips TM,Bowles C,Deisseroth A

    更新日期:1982-09-01 00:00:00

  • Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.

    abstract::Despite some advances, pancreatic ductal adenocarcinoma (PDAC) remains generally refractory to current treatments. Desmoplastic stroma, a consistent hallmark of PDAC, has emerged as a major source of therapeutic resistance and thus potentially promising targets for improved treatment. The glycan-binding protein galect...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3013

    authors: Martínez-Bosch N,Fernández-Barrena MG,Moreno M,Ortiz-Zapater E,Munné-Collado J,Iglesias M,André S,Gabius HJ,Hwang RF,Poirier F,Navas C,Guerra C,Fernández-Zapico ME,Navarro P

    更新日期:2014-07-01 00:00:00

  • Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.

    abstract::Organic anion transporting polypeptide 1B3 (OATP1B3, SLCO1B3) is normally expressed in hepatocytes. In this study, we showed frequent overexpression of OATP1B3 in colorectal adenocarcinomas. Quantitative reverse transcription-PCR analysis of 17 colon tumors indicated tumoral overexpression of OATP1B3 by approximately ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1984

    authors: Lee W,Belkhiri A,Lockhart AC,Merchant N,Glaeser H,Harris EI,Washington MK,Brunt EM,Zaika A,Kim RB,El-Rifai W

    更新日期:2008-12-15 00:00:00

  • Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.

    abstract::Ionizing radiation is a major tool for cancer treatment. The response of eukaryotic cells to ionizing radiation includes apoptosis, a process which requires activation of multiple genes. We sought to determine whether radiation-induced gene expression plays a role in radiation-induced apoptosis. We found Apo2 ligand (...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gong B,Almasan A

    更新日期:2000-10-15 00:00:00